Member Login
  1. Stocks
    2. /
  2. Smith & Nephew plc (LSE: SN.)
    3. /

LSE:SN. (Smith & Nephew plc)

About SN.

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Smith & Nephew plc (LSE: SN.) Latest News

    Investing Articles

    2 stocks I’d invest in today for my retirement

    | Peter Stephens

    These two companies could have bright futures.

    Read more »

    Investing Articles

    Smith & Nephew plc isn’t the only Footsie growth stock I’d buy on the dips

    | Roland Head

    Medical group Smith & Nephew plc (LON:SN) could be a great FTSE 100 (INDEXFTSE:UKX) buy during the next market correction.

    Read more »

    Investing Articles

    AstraZeneca plc isn’t the only way to play the world’s ageing population

    | Edward Sheldon, CFA

    AstraZeneca plc (LON: AZN) may have long-term potential, but could this 'niche' healthcare stock be a better way to play…

    Read more »

    Investing Articles

    This FTSE 100 stock can help you profit from an ageing population

    | Bilaal Mohamed

    Bilaal Mohamed sees an increase in demand for this FTSE 100 (INDEXFTSE:UKX) company's products.

    Read more »

    Investing Articles

    2 FTSE 100 shares that could make your fortune

    | Royston Wild

    Royston Wild looks at two FTSE 100 (INDEXFTSE: UKX) stocks that could make you rich.

    Read more »

    Investing Articles

    2 chances to make a million?

    | Peter Stephens

    Could these two stocks boost your portfolio returns?

    Read more »

    Investing Articles

    One FTSE 100 growth stock I wouldn’t touch with a bargepole

    | Paul Summers

    A recovery could take longer than expected at this battered stock.

    Read more »

    Investing Articles

    This FTSE 100 growth stock could be a better buy than AstraZeneca plc

    | Edward Sheldon, CFA

    AstraZeneca plc (LON: AZN) is a popular healthcare stock among UK investors. But is this FTSE 100 (INDEXFTSE:UKX) joint replacement…

    Read more »

    Investing Articles

    2 FTSE 100 stocks I’d buy and hold for 10 years

    | Royston Wild

    Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) shares that investors could buy now and love forever.

    Read more »

    Investing Articles

    Two growth stocks that could make you a millionaire

    | Peter Stephens

    These two shares offer a potent mix of growth and value potential.

    Read more »

    Investing Articles

    Why I’d buy and hold Smith & Nephew plc and Primary Health Properties plc forever

    | G A Chester

    G A Chester explains why Smith & Nephew plc (LON:SN) and Primary Health Properties plc (LON:PHP) are in his buy-and-hold-forever…

    Read more »

    Investing Articles

    Is Croda International plc a top FTSE 100 stock for blue-chip growth hunters?

    | Rupert Hargreaves

    Croda International plc's (LON: CRDA) growth makes it a perfect buy-and-forget share.

    Read more »